Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/175317
Cysteine and Folate metabolism are targetable vulnerabilities of metastatic colorectal cancer
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
With most cancer-related deaths resulting from metastasis, the development of new therapeutic approaches against metastatic colorectal cancer (mCRC) is essential to increasing patient survival. The metabolic adaptations that support mCRC remain undefined and their elucidation is crucial to identify potential therapeutic targets. Here, we employed a strategy for the rational identification of targetable metabolic vulnerabilities. This strategy involved first a thorough metabolic characterisation of same-patient-derived cell lines from primary colon adenocarcinoma (SW480), its lymph node metastasis (SW620) and a liver metastatic derivative (SW620-LiM2), and second, using a novel multi-omics integration workflow, identification of metabolic vulnerabilities specific to the metastatic cell lines. We discovered that the metastatic cell lines are selectively vulnerable to the inhibition of cystine import and folate metabolism, two key pathways in redox homeostasis. Specifically, we identified the system xCT and MTHFD1 genes as potential therapeutic targets, both individually and combined, for combating mCRC.
Subject
Subject (English)
Citation
Citation
TARRAGÓ-CELADA, Josep, et al. Cysteine and Folate metabolism are targetable vulnerabilities of metastatic colorectal cancer. Cancers. 2021. Vol. 13, num. 3, pags. 425. ISSN 2072-6694. [consulted: 8 of June of 2026]. Available at: https://hdl.handle.net/2445/175317